This company listing is no longer active
Resumen de acción QTNT.Q
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Quotient Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.039 |
| 52 Week High | US$21.13 |
| 52 Week Low | US$0.032 |
| Beta | 2.37 |
| 1 Month Change | 10.64% |
| 3 Month Change | -28.77% |
| 1 Year Change | -99.72% |
| 3 Year Change | -99.99% |
| 5 Year Change | -99.99% |
| Change since IPO | -99.99% |
Noticias y actualizaciones recientes
Recent updates
Quotient expands MosaiQ Innovator's Circle
Aug 24Quotient teams up with InfYnity Biomarkers to advance infectious disease testing
Jul 12Analysts Just Shaved Their Quotient Limited (NASDAQ:QTNT) Forecasts Dramatically
Feb 10
Quotient beats on revenue; issues guidance
Jun 01Here's Why Quotient (NASDAQ:QTNT) Can Afford Some Debt
Apr 12A Look At Quotient's (NASDAQ:QTNT) Share Price Returns
Mar 08Quotient EPS beats by $0.01, beats on revenue
Feb 01Read This Before Selling Quotient Limited (NASDAQ:QTNT) Shares
Feb 01Is Quotient (NASDAQ:QTNT) A Risky Investment?
Jan 04
Quotient operations chief resigns
Dec 22Quotient drops ~7% as FDA requires additional data for regulatory clearance
Dec 10Quotient (NASDAQ:QTNT) Shareholders Have Enjoyed A 58% Share Price Gain
Dec 07Quotient's Disruptive MosaiQ Platform And Its Upcoming Approval
Nov 17Quotient EPS beats by $0.16, beats on revenue
Nov 02Rentabilidad de los accionistas
| QTNT.Q | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 14.7% | -0.9% | -0.7% |
| 1Y | -99.7% | -2.0% | 22.3% |
Rentabilidad vs. Industria: QTNT.Q underperformed the US Medical Equipment industry which returned 12.7% over the past year.
Rentabilidad vs. Mercado: QTNT.Q underperformed the US Market which returned 14% over the past year.
Volatilidad de los precios
| QTNT.Q volatility | |
|---|---|
| QTNT.Q Average Weekly Movement | 68.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: QTNT.Q's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: QTNT.Q's weekly volatility has increased from 46% to 68% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2007 | 432 | Manuel Mendez | www.quotientbd.com |
Resumen de fundamentos de Quotient Limited
| Estadísticas fundamentales de QTNT.Q | |
|---|---|
| Capitalización bursátil | US$821.15k |
| Beneficios(TTM) | -US$124.03m |
| Ingresos (TTM) | US$37.41m |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está QTNT.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de QTNT.Q | |
|---|---|
| Ingresos | US$37.41m |
| Coste de los ingresos | US$37.13m |
| Beneficio bruto | US$279.00k |
| Otros gastos | US$124.31m |
| Beneficios | -US$124.03m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -5.89 |
| Margen bruto | 0.75% |
| Margen de beneficio neto | -331.54% |
| Ratio deuda/patrimonio | -126.2% |
¿Cómo se ha desempeñado QTNT.Q a largo plazo?
Ver rendimiento histórico y comparativa